AccuStem Sciences, Inc.
ACUT
$0.16
-$0.07-28.89%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.11% | 12.07% | 7.92% | 18.22% | -6.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.56% | 26.97% | 16.68% | 17.03% | -6.50% |
| Operating Income | -7.18% | -26.97% | -16.68% | -17.03% | 6.50% |
| Income Before Tax | -7.18% | -26.97% | -16.68% | -17.03% | 6.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.18% | -26.97% | -16.68% | -17.03% | 6.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.18% | -26.97% | -16.68% | -17.03% | 6.50% |
| EBIT | -7.18% | -26.97% | -16.68% | -17.03% | 6.50% |
| EBITDA | -7.32% | -27.23% | -16.93% | -17.24% | 6.43% |
| EPS Basic | 14.55% | 6.43% | 11.47% | 4.28% | 17.21% |
| Normalized Basic EPS | 14.49% | 6.41% | 11.54% | 4.34% | 17.27% |
| EPS Diluted | 14.55% | 6.43% | 11.47% | 4.28% | 17.21% |
| Normalized Diluted EPS | 14.49% | 6.41% | 11.54% | 4.34% | 17.27% |
| Average Basic Shares Outstanding | 24.02% | 36.46% | 33.25% | 24.64% | 14.23% |
| Average Diluted Shares Outstanding | 24.02% | 36.46% | 33.25% | 24.64% | 14.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |